Adenomyosis and endometriosis both involve endometrial-like tissue growing where it should not, but they differ in where that tissue ends up. In endometriosis, tissue resembling the uterine lining implants outside the uterus, on surfaces like the ovaries, fallopian tubes, or pelvic lining. In adenomyosis, that tissue burrows into the muscular wall of the uterus itself. The two conditions share enough biology that some researchers have asked whether they are really just different faces of the same disease, yet in the clinic they often look, feel, and behave quite differently.
Where the Tissue Goes and Why It Matters
The uterus has three layers. The innermost is the endometrium, the lining that thickens each month and sheds during menstruation. Beneath it is the myometrium, a thick layer of smooth muscle. In adenomyosis, endometrial glands and supporting tissue push down into the myometrium, sometimes scattered throughout the entire muscle wall (diffuse adenomyosis) and sometimes concentrated in a single area that can form a mass called an adenomyoma. Because the misplaced tissue still responds to hormonal cycles, it swells and bleeds within the muscle, causing the uterus to enlarge and become boggy and tender.
Endometriosis, by contrast, takes up residence outside the uterus altogether. The most widely discussed explanation involves retrograde menstruation, where menstrual blood flows backward through the fallopian tubes and deposits endometrial cells in the pelvis, though immune dysfunction, stem cell involvement, and other pathways also play a role.1PubMed Central. The Main Theories on the Pathogenesis of Endometriosis Endometrial stem or progenitor cells may be among the cells that seed these distant implants.2PubMed Central. New concepts on the etiology of endometriosis The implants trigger chronic inflammation, can form adhesions binding organs together, and in the ovaries often produce fluid-filled cysts called endometriomas.
Despite these different destinations, a unifying theory proposes that both conditions start with chronic micro-trauma at the boundary between the endometrium and the myometrium. Repeated, exaggerated uterine contractions during menstruation may injure that boundary layer, kicking off a tissue-injury-and-repair cycle that boosts local estrogen production and drives abnormal tissue growth in both directions, inward (adenomyosis) and outward (endometriosis).3PubMed Central. An Appraisal of the Tissue Injury and Repair (TIAR) Theory on the Pathogenesis of Endometriosis and Adenomyosis That shared starting point helps explain why the two diseases so often occur together.
How Often They Overlap
Adenomyosis and endometriosis co-occur far more than chance would predict. A recent large-scale systematic review and meta-analysis found adenomyosis in about 42% of people already diagnosed with endometriosis.4PubMed Central. Global prevalence of adenomyosis and endometriosis: a systematic review and meta-analysis The overlap is so substantial that some researchers argue the two conditions are different phenotypes of a single underlying disease process.5PubMed Central. Are Adenomyosis and Endometriosis Phenotypes of the Same Disease Process?
Interestingly, the type of adenomyosis seems to predict the strength of the link. A study using MRI to classify adenomyosis by its location within the muscle wall found that external adenomyosis, where lesions sit in the outer part of the myometrium away from the uterine lining, co-existed with endometriosis in over 96% of cases, and the endometriosis tended to be the deep infiltrating type. Internal adenomyosis, closer to the lining, was paired with endometriosis only about 62% of the time, and the endometriosis was usually less severe.6Human Reproduction. Adenomyosis of the inner and outer myometrium are associated with different clinical profiles That pattern supports the idea that external adenomyosis may share more biology with endometriosis than internal adenomyosis does.
Symptoms That Set Them Apart
Both conditions cause pelvic pain, but the texture of the symptoms is different. Heavy menstrual bleeding is the hallmark of adenomyosis. In one comparative study, about 64% of people with adenomyosis reported heavy periods, compared with only 19% of those with endometriosis.7Journal of Endometriosis and Uterine Disorders. Adenomyosis and endometriosis: a differential diagnosis by clinical symptoms If your main complaint is soaking through pads or tampons at a rate that disrupts your day, adenomyosis deserves a close look.
Endometriosis, on the other hand, tends to produce more intense pain symptoms. The same study found that severe menstrual cramps and chronic pelvic pain that persists outside of periods were both significantly more common in endometriosis. Pain during sex was roughly equal between the two groups. People unlucky enough to have both conditions at once carried the heaviest symptom burden of all, with more bleeding and more pain than either condition alone.8Journal of Endometriosis and Uterine Disorders. Adenomyosis and endometriosis: a differential diagnosis by clinical symptoms
A useful rule of thumb: if the dominant problem is flooding periods with a swollen, achy uterus, think adenomyosis. If the dominant problem is severe pain that extends well beyond menstruation and possibly involves the bowels or bladder, think endometriosis. But these are tendencies, not rules, and the overlap zone is wide.
Why They Hurt in Different Ways
The pain mechanisms are not identical. In endometriosis, lesions provoke a local inflammatory environment that stimulates the growth of new nerve fibers. Research has found that endometriotic tissue is rich in nerve growth factor (NGF), which recruits and sustains nerve fibers in and around the implants.9PubMed Central. Endometriosis-associated nerve fibers and pain Deep infiltrating endometriosis, in particular, tends to sit in areas packed with nerves and produces higher nerve fiber densities than superficial peritoneal lesions or ovarian endometriomas.10Human Reproduction Update. Peripheral changes in endometriosis-associated pain
Deep adenomyotic nodules, a subtype that often overlaps with deep infiltrating endometriosis, take nerve involvement a step further. Researchers have found that these nodules can actually invade surrounding nerves, with endometriotic tissue growing into and around nerve bundles. That direct nerve infiltration was not seen in peritoneal or ovarian endometriosis.11Human Reproduction. Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis For classic adenomyosis within the uterine wall, pain likely stems more from the muscle stretching, swelling, and increased intrauterine pressure that come with cyclical bleeding inside the myometrium.
How Each Condition Is Diagnosed
Neither condition has a simple blood test. Diagnosis relies heavily on imaging, and the tools look different depending on what you are searching for.
For adenomyosis, both transvaginal ultrasound and MRI can pick up characteristic signs. On MRI, the classic finding is thickening of the junctional zone, the transitional layer between the endometrium and the myometrium. A junctional zone thicker than 12 mm has traditionally been considered strongly suggestive of adenomyosis, while less than 8 mm generally rules it out.12PubMed Central. MRI for adenomyosis: a pictorial review However, more recent work has challenged that neat cutoff. A prospective study found that maximum junctional zone thickness alone did not reliably distinguish people with adenomyosis from those without it. Instead, the irregularity of the junctional zone, meaning its edges were broken up and disrupted rather than smooth, was a far better predictor.13PubMed. Diagnosing adenomyosis with MRI: a prospective study revisiting the junctional zone thickness cutoff of 12 mm as a diagnostic marker Tiny bright spots on MRI, representing trapped blood or dilated glands, add further confidence. These bright foci have a very high positive predictive value for adenomyosis, though they are present in less than half of confirmed cases.14PubMed Central. MRI for adenomyosis: a pictorial review
Ultrasound and MRI measure the junctional zone a bit differently. On MRI the boundary between the junctional zone and the outer myometrium appears abrupt, but histologically the transition is gradual, meaning the two imaging methods do not always agree on thickness measurements.15PubMed. Uterine junctional zone and adenomyosis: comparison of MRI, transvaginal ultrasound and histology In practical terms, an experienced sonographer can often diagnose adenomyosis on ultrasound alone, looking for features like asymmetric thickening of the uterine walls, small cysts within the muscle, and lines radiating from the endometrium into the myometrium.
For endometriosis, transvaginal ultrasound is the first-line tool for detecting ovarian endometriomas and deep infiltrating lesions. MRI adds value when ultrasound is inconclusive or when mapping the full extent of disease before surgery. Superficial peritoneal endometriosis, however, is often invisible to both ultrasound and MRI; laparoscopy with biopsy remains the only reliable way to confirm it.
Fertility Effects
Both conditions reduce the odds of getting pregnant, but through somewhat different mechanisms. Endometriosis can distort pelvic anatomy so that the tubes cannot pick up an egg, shrink the ovarian reserve when endometriomas damage ovarian tissue, and create a toxic peritoneal environment where inflammation and oxidative stress impair sperm function and embryo survival.16PubMed Central. Ethiopathogenic mechanisms of endometriosis-related infertility
Adenomyosis interferes more at the implantation stage. It distorts the uterine cavity, disrupts the coordinated contractions that help transport sperm and embryos, alters hormone receptor signaling in the lining, and reduces the expression of molecules that an embryo needs to latch on.17PubMed Central. Adenomyosis and Infertility: A Literature Review In IVF, adenomyosis is increasingly recognized as a factor that lowers embryo transfer success even when egg quality is good.
A review comparing both conditions found that reduced pregnancy and live birth rates, along with increased miscarriage, were seen in both, but the negative effect on these outcomes was actually larger for adenomyosis than for endometriosis.18PubMed. Association of endometriosis and adenomyosis with pregnancy and infertility That finding runs counter to the popular perception that endometriosis is the bigger fertility threat. Adenomyosis has simply received less attention until recently.
Pregnancy Risks Once You Do Conceive
The impact does not end at a positive pregnancy test. People with adenomyosis face elevated risks of several obstetric complications, including preeclampsia, preterm delivery, fetal malpresentation, postpartum hemorrhage, and babies that are small for gestational age.19PubMed. Association of endometriosis and adenomyosis with pregnancy and infertility A large Japanese perinatal database study confirmed significantly higher rates of placenta previa and preterm birth in pregnancies affected by endometriosis or adenomyosis, with the odds of placenta previa roughly tripled.20PubMed. Increased risk of placenta previa and preterm birth in pregnant women with endometriosis/adenomyosis
If you have either diagnosis and become pregnant, closer monitoring during pregnancy is warranted. These are not guarantees of complications, but the baseline risk is higher than average, and obstetricians who know about the diagnosis can adjust their surveillance accordingly.
Treatment Approaches and Where They Diverge
Medical treatment for both conditions leans heavily on hormonal suppression. Progestins, combined oral contraceptives, and GnRH agonists can quiet symptoms in both diseases by reducing estrogen’s stimulating effect on misplaced tissue. But the practical details differ.
For adenomyosis, the levonorgestrel-releasing intrauterine system (a hormonal IUD) has become a go-to option. A randomized trial comparing it head-to-head with combined oral contraceptives in adenomyosis found that both reduced pain and bleeding, but the IUD outperformed the pill on bleeding control.21Contraception. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial Another trial comparing the hormonal IUD with dienogest, an oral progestin widely used in both conditions, found both effective for pelvic pain and bleeding. The IUD had a slight edge on bleeding, while dienogest showed better improvement in overall quality of life.22PubMed Central. Comparison of efficacy between levonorgestrel intrauterine system and dienogest in adenomyosis: a randomized clinical trial
Not all adenomyosis responds equally to progestin therapy. A study on progesterone resistance found that intrinsic adenomyosis (the kind growing inward from the lining) responded much better to the hormonal IUD than advanced or extrinsic adenomyosis, where resistance was more common. Whether you respond could become apparent within a month of starting treatment.
For endometriosis, the same hormonal menu applies, though the choice often depends on disease location. Deep bowel or bladder endometriosis may not respond adequately to hormones and frequently requires surgical excision. Endometriomas larger than a few centimeters are typically removed surgically as well. Having concurrent adenomyosis adds surgical risk: a study of deep endometriosis surgery found that patients who also had adenomyosis had a complication rate of about 34%, compared with roughly 13% in those without it, representing more than a fourfold increase in risk even after accounting for other variables.23PubMed Central. Adenomyosis is an independent risk factor for complications in deep endometriosis laparoscopic surgery
Non-Surgical Alternatives for Adenomyosis
Because adenomyosis lives within the uterine wall, it cannot be excised as neatly as an endometriotic implant on the peritoneum. When hormones fail and the patient wants to preserve the uterus, two minimally invasive options have gained ground.
Uterine artery embolization, which starves the tissue of blood supply by blocking the arteries feeding the uterus, has shown sustained symptom improvement in roughly three-quarters of patients with isolated adenomyosis at follow-ups beyond a year, and in larger series with up to seven years of data, about 82% maintained symptom control and avoided hysterectomy.24PubMed Central. An update on uterine artery embolization for uterine leiomyomata and adenomyosis of the uterus
High-intensity focused ultrasound (HIFU) is a newer approach that uses concentrated sound waves to heat and destroy adenomyotic tissue without any incision. Studies show it relieves painful periods in roughly 84% of patients and substantially reduces lesion volume, with results tracked out to about three years.25PubMed Central. An update on uterine artery embolization for uterine leiomyomata and adenomyosis of the uterus A retrospective cohort study reported a treatment success rate over 96% in adenomyosis cases, with no serious adverse reactions.26PubMed. Retrospective cohort study on the efficacy and safety of high-intensity focused ultrasound in non-invasive treatment of uterine leiomyomas and adenomyosis These options do not have the decades of outcome data that hysterectomy does, but they are especially valuable for people who want to keep their uterus or who are poor candidates for surgery.
Who Gets Which Condition and When
Endometriosis typically announces itself early, often in the teens or twenties when menstrual pain becomes severe enough to interfere with school or work. Adenomyosis has historically been considered a disease of older, parous women, in large part because the diagnosis used to require examining the uterus after hysterectomy, and hysterectomies tend to happen later in life. Now that non-invasive imaging can catch it earlier, the picture is changing. Still, classic adenomyosis in adolescents remains rare, with only unusual cystic forms reported in that age group.27PubMed. Adenomyosis: a life-cycle approach
The traditionally cited risk factors for adenomyosis, such as multiple pregnancies and prior uterine surgery, are increasingly uncertain. Active disease has been found in women who have never been pregnant, and it persists in pre- and peri-menopausal women as well as in postmenopausal women taking certain medications like tamoxifen.28PubMed. Adenomyosis: a life-cycle approach The old portrait of adenomyosis as something that only afflicts middle-aged mothers is outdated.
The Diagnostic Delay Problem
Endometriosis is notorious for long diagnostic delays, often averaging seven to ten years from symptom onset to confirmed diagnosis. Adenomyosis historically had an even bigger blind spot because it was considered a pathological diagnosis, something you named only after looking at the removed uterus under a microscope. The shift to diagnosing adenomyosis by imaging criteria is relatively recent, and many clinicians still think of it as a secondary finding rather than a primary condition worth investigating on its own.
That delay matters because the two conditions can mask each other. A person with painful, heavy periods might get diagnosed with endometriosis through laparoscopy, have endometriotic implants treated, and still have debilitating symptoms because undiagnosed adenomyosis in the uterine wall was never addressed. Conversely, someone told they have adenomyosis and given a hormonal IUD might still have severe non-menstrual pelvic pain because deep endometriosis elsewhere in the pelvis was never looked for. Clinicians who suspect one should routinely evaluate for the other.
Emerging Research on Microbiome Connections
An intriguing line of research has begun linking adenomyosis to shifts in the microbial communities of the uterus, vagina, and gut. A systematic review cataloging the available evidence found that people with adenomyosis showed increased abundance of certain bacterial groups, including Firmicutes and several specific species, along with decreased levels of other families. The vaginal microbiome in adenomyosis patients tended to show community profiles associated with higher bacterial diversity and reduced dominance of Lactobacillus, the genus that typically keeps the vaginal environment acidic and protective.29PubMed Central. Deciphering the relationship between adenomyosis and the microbiota: a systematic review
This is early-stage work, and whether these microbial shifts cause adenomyosis, result from it, or simply tag along is unknown. Endometriosis has a similar (and slightly more developed) body of research linking it to peritoneal and gut microbiome changes. The overlap with immune dysregulation in both diseases makes the microbiome a plausible player, but there is nothing close to a clinical application yet. It is the kind of research that could eventually inform treatment, but right now it mostly tells us how much we still do not understand about what initiates and sustains these conditions.
Financial and Quality-of-Life Burden
Both conditions carry substantial costs, though the burden plays out differently. Direct hospital costs tend to be highest for uterine fibroids in the short term, but over a two-year horizon, endometriosis and fibroids lead the pack. Where endometriosis stands out is in lost productivity: at two years, endometriosis patients showed markedly higher productivity costs than any other benign gynecological condition studied, reflecting the chronic, fluctuating nature of the pain and the repeated medical visits, imaging, and surgeries involved.30PLOS ONE. Where does the money go to? Cost analysis of gynecological patients with a benign condition
Adenomyosis, historically lumped with “abnormal uterine bleeding” in billing and research databases, has been harder to study from a cost perspective. But qualitative research with affected individuals paints a picture of disrupted careers, strained relationships, and the psychological toll of involuntary childlessness. The emotional weight of living with a condition that many doctors still dismiss or fail to diagnose should not be underestimated. It compounds the physical burden in ways that cost analyses rarely capture.